Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CCBR-SYNARC, BioClinica To Merge | Contract Pharma
Breaking News

CCBR-SYNARC, BioClinica To Merge

Jeffrey McMullen appointed chairman

CCBR-SYNARC and BioClinica have signed an agreement to merge, creating a global provider of outsourced clinical services from centers throughout Asia, Europe and The Americas. The combined company will offer a portfolio of services for conducting and managing global clinical trials. The transaction is expected to close in 1Q14. Financial terms were not disclosed.
 
Jeffrey McMullen, vice chairman of inVentiv Health, Inc., will serve as chairman of the combined company. Mark Weinstein, president and chief executive officer of BioClinica, will serve as chief executive officer.
 
The combined company will offer medical imaging services across multiple therapeutic areas, a worldwide network of research centers dedicated to recruiting patients for global trials, provide technology and consulting services, monitor cardiac safety of compounds, as well as provide central lab services.
 
Mr. McMullen said, “This is a ground-breaking merger that will bring together two of the industry’s most experienced providers of specialized clinical trial services. Combining CCBR-SYNARC and BioClinica into a single company will offer customers exceptional scientific expertise and sophisticated technologies to support their drug development processes and accelerate the pace of their innovation.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters